Christopher John Burns
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.6MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 30, 2020 | NIH | SBIR Phase II Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas | $1.0M | VENATORX PHARMACEUTICALS INC |
| Jan 18, 2019 | NIH | SBIR Phase II Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas | $1.0M | VENATORX PHARMACEUTICALS INC |
| Feb 7, 2018 | NIH | SBIR Phase II Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas | $1.0M | VENATORX PHARMACEUTICALS INC |
| May 31, 2016 | NIH | SBIR Phase I Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas | $300K | VENATORX PHARMACEUTICALS INC |
| Aug 4, 2015 | NIH | SBIR Phase II Preserving beta-lactam utility vs pathogens producing any class of beta-lactamase | $1.0M | VENATORX PHARMACEUTICALS INC |
| Jun 15, 2015 | NIH | SBIR Phase I Novel Combination Product with Activity Against MRSA, MDR-Enterics and Pseudomonas | $300K | VENATORX PHARMACEUTICALS INC |
Peer ranks
Federal funding#309
Awards as PI#315
Patents#273
Companies
- VENATORX PHARMACEUTICALS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.